|
1
|
Goy A and Kahl B: Mantle cell lymphoma:
The promise of new treatment options. Crit Rev Oncol Hematol.
80:69–86. 2011. View Article : Google Scholar
|
|
2
|
Chihara D, Ito H, Matsuda T, Shibata A,
Katsumi A, Nakamura S, Tomotaka S, Morton LM, Weisenburger DD and
Matsuo K: Differences in incidence and trends of haematological
malignancies in Japan and the United States. Br J Haematol.
164:536–545. 2014. View Article : Google Scholar :
|
|
3
|
Jares P, Colomer D and Campo E: Molecular
pathogenesis of mantle cell lymphoma. J Clin Invest. 122:3416–3423.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mozos A, Royo C, Hartmann E, De Jong D,
Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, et
al: SOX11 expression is highly specific for mantle cell lymphoma
and identifies the cyclin D1-negative subtype. Haematologica.
94:1555–1562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salaverria I, Royo C, Carvajal-Cuenca A,
Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G,
Klapper W, et al: CCND2 rearrangements are the most frequent
genetic events in cyclin D1(−) mantle cell lymphoma. Blood.
121:1394–1402. 2013. View Article : Google Scholar :
|
|
6
|
Kridel R, Meissner B, Rogic S, Boyle M,
Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C,
Ben-Neriah S, et al: Whole transcriptome sequencing reveals
recurrent NOTCH1 mutations in mantle cell lymphoma. Blood.
119:1963–1971. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoster E, Dreyling M, Klapper W,
Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M,
Reiser M, Metzner B, Einsele H, et al; German Low Grade Lymphoma
Study Group (GLSG). European Mantle Cell Lymphoma Network: A small
prognostic index (MIPI) for patients with advanced-stage mantle
cell lymphoma. Blood. 111:558–565. 2008. View Article : Google Scholar
|
|
8
|
Nordström L, Sernbo S, Eden P, Grønbaek K,
Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E,
Sundström C, et al: SOX11 and TP53 add prognostic information to
MIPI in a homogenously treated cohort of mantle cell lymphoma - a
Nordic Lymphoma Group study. Br J Haematol. 166:98–108. 2014.
View Article : Google Scholar
|
|
9
|
Kimura Y, Sato K, Arakawa F, Karube K,
Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, et
al: Mantle cell lymphoma shows three morphological evolutions of
classical, intermediate, and aggressive forms, which occur in
parallel with increased labeling index of cyclin D1 and Ki-67.
Cancer Sci. 101:806–814. 2010. View Article : Google Scholar
|
|
10
|
Kimura Y, Arakawa F, Kiyasu J, Miyoshi H,
Yoshida M, Ichikawa A, Niino D, Sugita Y, Okamura T, Doi A, et al:
The Wnt signaling pathway and mitotic regulators in the initiation
and evolution of mantle cell lymphoma: Gene expression analysis.
Int J Oncol. 43:457–468. 2013.PubMed/NCBI
|
|
11
|
Teshima K, Nara M, Watanabe A, Ito M,
Ikeda S, Hatano Y, Oshima K, Seto M, Sawada K and Tagawa H:
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an
anti-apoptotic potential in the side population of refractory
mantle cell lymphoma. Oncogene. 33:2191–2203. 2014. View Article : Google Scholar
|
|
12
|
Yamagishi M, Nakano K, Miyake A, Yamochi
T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S,
Utsunomiya A, et al: Polycomb-mediated loss of miR-31 activates
NIK-dependent NF-κB pathway in adult T cell leukemia and other
cancers. Cancer Cell. 21:121–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu AM, Yao TJ, Wang W, Wong KF, Lee NP,
Fan ST, Poon RT, Gao C and Luk JM: Circulating miR-15b and miR-130b
in serum as potential markers for detecting hepatocellular
carcinoma: A retrospective cohort study. BMJ Open. 2:e0008252012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES,
Liu C, Liu Z, Lachel CM, Deffenbacher K, Greiner TC, et al:
Genome-wide miRNA profiling of mantle cell lymphoma reveals a
distinct subgroup with poor prognosis. Blood. 119:4939–4948. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Navarro A, Clot G, Prieto M, Royo C,
Vegliante MC, Amador V, Hartmann E, Salaverria I, Beà S,
Martín-Subero JI, et al: microRNA expression profiles identify
subtypes of mantle cell lymphoma with different clinicobiological
characteristics. Clin Cancer Res. 19:3121–3129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshida S, Arakawa F, Higuchi F, Ishibashi
Y, Goto M, Sugita Y, Nomura Y, Niino D, Shimizu K, Aoki R, et al:
Gene expression analysis of rheumatoid arthritis synovial lining
regions by cDNA microarray combined with laser microdissection:
Up-regulation of inflammation-associated STAT1, IRF1, CXCL9,
CXCL10, and CCL5. Scand J Rheumatol. 41:170–179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saeed AI, Sharov V, White J, Li J, Liang
W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et
al: TM4: A free, open-source system for microarray data management
and analysis. Biotechniques. 34:374–378. 2003.PubMed/NCBI
|
|
18
|
Visone R, Veronese A, Balatti V and Croce
CM: MiR-181b: New perspective to evaluate disease progression in
chronic lymphocytic leukemia. Oncotarget. 3:195–202. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tagawa H, Karnan S, Suzuki R, Matsuo K,
Zhang X, Ota A, Morishima Y, Nakamura S and Seto M: Genome-wide
array-based CGH for mantle cell lymphoma: Identification of
homozygous deletions of the proapoptotic gene BIM. Oncogene.
24:1348–1358. 2005. View Article : Google Scholar
|
|
20
|
Fernàndez V, Salamero O, Espinet B, Solé
F, Royo C, Navarro A, Camacho F, Beà S, Hartmann E, Amador V, et
al: Genomic and gene expression profiling defines indolent forms of
mantle cell lymphoma. Cancer Res. 70:1408–1418. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simone NL, Soule BP, Ly D, Saleh AD,
Savage JE, Degraff W, Cook J, Harris CC, Gius D and Mitchell JB:
Ionizing radiation-induced oxidative stress alters miRNA
expression. PLoS One. 4:e63772009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ofir M, Hacohen D and Ginsberg D: MiR-15
and miR-16 are direct transcriptional targets of E2F1 that limit
E2F-induced proliferation by targeting cyclin E. Mol Cancer Res.
9:440–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rahman M, Lovat F, Romano G, Calore F,
Acunzo M, Bell EH and Nana-Sinkam P: miR-15b/16-2 regulates factors
that promote p53 phosphorylation and augments the DNA damage
response following radiation in the lung. J Biol Chem.
289:26406–26416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH,
Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res (Phila).
5:665–674. 2012. View Article : Google Scholar
|
|
25
|
Sun G, Shi L, Yan S, Wan Z, Jiang N, Fu L,
Li M and Guo J: MiR-15b targets cyclin D1 to regulate proliferation
and apoptosis in glioma cells. BioMed Res Int. 2014:6878262014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lovat F, Fassan M, Gasparini P, Rizzotto
L, Cascione L, Pizzi M, Vicentini C, Balatti V, Palmieri D,
Costinean S, et al: miR-15b/16-2 deletion promotes B-cell
malignancies. Proc Natl Acad Sci USA. 112:11636–11641. 2015.
View Article : Google Scholar : PubMed/NCBI
|
